These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37794659)

  • 1. Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
    Bauer RN; Xie Y; Beaudin S; Wiltshire L; Wattie J; Muñoz C; Alsaji N; Oliveria JP; Ju X; MacLean J; Sommer DD; Keith PK; Satia I; Cusack RP; O'Byrne PM; Sperinde G; Hokom M; Li O; Banerjee P; Chen C; Staton T; Sehmi R; Gauvreau GM
    Clin Exp Allergy; 2023 Nov; 53(11):1187-1197. PubMed ID: 37794659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma.
    Xie Y; Ju X; Beaudin S; Wiltshire L; Oliveria JP; MacLean J; Sommer DD; Cusack R; Li O; Banerjee P; Keith PK; O'Byrne PM; Bauer RN; Staton T; Gauvreau GM; Sehmi R
    Allergy; 2021 Sep; 76(9):2797-2808. PubMed ID: 33784411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.
    Ellis AK; Soliman M; Steacy L; Boulay MÈ; Boulet LP; Keith PK; Vliagoftis H; Waserman S; Neighbour H
    Allergy Asthma Clin Immunol; 2015; 11(1):16. PubMed ID: 25945101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
    Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
    J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical symptoms and biomarkers of Bermuda grass-induced allergic rhinitis using the nasal allergen challenge model.
    Rawls M; Thiele J; Adams DE; Steacy LM; Ellis AK
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):608-615.e2. PubMed ID: 32173484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability of nasal allergen challenge results: Further validation of the allergic rhinitis clinical investigator collaborative protocols.
    Soliman M; Steacy LM; Thiele J; Adams DE; Neighbour HL; Ellis AK
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):607-613. PubMed ID: 29432965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
    Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
    Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Medical Therapy in Allergic Rhinitis: A Systematic Review and Meta-Analysis.
    Zhang K; Li AR; Miglani A; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2022 Mar; 36(2):269-280. PubMed ID: 34546814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial.
    Mårtensson A; Nordström FU; Cervin-Hoberg C; Lindstedt M; Sakellariou C; Cervin A; Greiff L
    Clin Exp Allergy; 2022 Jun; 52(6):774-783. PubMed ID: 35075723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.
    Ellis AK; Tsitoura DC; Quint D; Powley W; Lee LA
    Clin Exp Allergy; 2017 Sep; 47(9):1193-1203. PubMed ID: 28681506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.
    Neighbour H; Soliman M; Steacy LM; Hickey P; Forbes B; Larché M; Ellis AK
    Clin Transl Allergy; 2018; 8():15. PubMed ID: 29682277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and reproducibility of nasal allergen challenge.
    Eguiluz-Gracia I; Testera-Montes A; González M; Pérez-Sánchez N; Ariza A; Salas M; Moreno-Aguilar C; Campo P; Torres MJ; Rondon C
    Allergy; 2019 Jun; 74(6):1125-1134. PubMed ID: 30667530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis.
    Hoang MP; Chitsuthipakorn W; Seresirikachorn K; Snidvongs K
    Rhinology; 2022 Aug; 60(4):242-251. PubMed ID: 35379997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
    Greiff L; Persson CG; Svensson C; Enander I; Andersson M
    J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses.
    Erin EM; Leaker BR; Zacharasiewicz A; Higgins LA; Nicholson GC; Boyce MJ; de Boer P; Jones RC; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2006 Apr; 36(4):458-64. PubMed ID: 16630150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
    Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis.
    Boot JD; Chandoesing P; de Kam ML; Mascelli MA; Das AM; Gerth van Wijk R; de Groot H; Verhoosel R; Hiemstra PS; Diamant Z
    J Investig Allergol Clin Immunol; 2008; 18(6):433-42. PubMed ID: 19123434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.